A multicenter single-arm trial of sintilimab in combination with chemotherapy for neoadjuvant treatment of resectable esophageal cancer (SIN-ICE study)

BACKGROUND: Preoperative chemotherapy or chemoradiotherapy is the standard treatment for resectable esophageal cancer (EC); however, it is associated with increased postoperative complications and mortality. Recently, Immune Checkpoint inhibitors have been incorporated in the treatment of advanced E...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Hongtao, Wang, Tianhu, Luo, Zhilin, Wang, Xiaoyuan, Liu, Honggang, Tong, Liping, Dong, Xiaoping, Zhang, Yong, Valmasoni, Michele, Kidane, Biniam, Almhanna, Khaldoun, Wiesel, Ory, Pang, Sainan, Ma, Jianqun, Yan, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667140/
https://www.ncbi.nlm.nih.gov/pubmed/34988209
http://dx.doi.org/10.21037/atm-21-6102

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667140/
https://www.ncbi.nlm.nih.gov/pubmed/34988209
http://dx.doi.org/10.21037/atm-21-6102

Ejemplares similares